Alumis, Inc. (ALMS)
6.85
-0.36
(-4.99%)
USD |
NASDAQ |
Oct 02, 16:00
6.845
0.00 (0.00%)
After-Hours: 20:00
Alumis Price : 6.85 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 7.28 | 7.31 | 6.635 | 6.85 | 2.625M |
| Oct 01, 2026 | 7.40 | 7.48 | 7.15 | 7.21 | 2.131M |
| Sep 30, 2026 | 7.35 | 7.555 | 7.15 | 7.39 | 1.403M |
| Sep 29, 2026 | 7.16 | 7.41 | 7.13 | 7.29 | 1.668M |
| Sep 28, 2026 | 7.10 | 7.22 | 6.83 | 7.16 | 2.245M |
| Sep 25, 2026 | 7.33 | 7.38 | 7.035 | 7.10 | 1.724M |
| Sep 24, 2026 | 7.43 | 7.45 | 7.22 | 7.29 | 2.605M |
| Sep 23, 2026 | 8.03 | 8.075 | 7.31 | 7.44 | 2.695M |
| Sep 22, 2026 | 8.01 | 8.14 | 7.67 | 8.11 | 2.525M |
| Sep 21, 2026 | 7.82 | 7.92 | 7.56 | 7.90 | 2.433M |
| Sep 18, 2026 | 7.83 | 7.905 | 7.535 | 7.77 | 6.393M |
| Sep 17, 2026 | 8.03 | 8.11 | 7.755 | 7.82 | 3.515M |
| Sep 16, 2026 | 8.45 | 8.47 | 7.79 | 7.94 | 4.801M |
| Sep 15, 2026 | 9.18 | 9.20 | 8.31 | 8.40 | 4.005M |
| Sep 14, 2026 | 9.25 | 9.356 | 9.02 | 9.22 | 4.028M |
| Sep 11, 2026 | 9.99 | 10.10 | 9.14 | 9.18 | 3.434M |
| Sep 10, 2026 | 10.55 | 10.55 | 9.65 | 9.90 | 4.732M |
| Sep 09, 2026 | 10.49 | 10.67 | 9.770 | 9.80 | 3.879M |
| Sep 08, 2026 | 11.05 | 11.22 | 10.25 | 10.58 | 4.491M |
| Sep 04, 2026 | 11.23 | 11.60 | 11.01 | 11.10 | 3.078M |
| Sep 03, 2026 | 10.38 | 11.92 | 10.31 | 11.36 | 7.550M |
| Sep 02, 2026 | 10.16 | 10.77 | 9.950 | 10.35 | 10.38M |
| Sep 01, 2026 | 9.93 | 11.06 | 8.75 | 9.47 | 28.40M |
| Aug 31, 2026 | 22.29 | 22.54 | 21.28 | 21.81 | 1.373M |
| Aug 28, 2026 | 22.83 | 23.28 | 22.35 | 22.38 | 655336.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 256.03 |
| Corcept Therapeutics, Inc. | 116.23 |
| Aclaris Therapeutics, Inc. | 4.39 |
| BioAge Labs, Inc. | 6.61 |
| ANI Pharmaceuticals, Inc. | 72.18 |
Price Related Metrics
| PS Ratio | 106.84 |
| Price to Book Value | 1.947 |
| Earnings Yield | -55.61% |
| Market Cap | 880.26M |